SciSparc Acquires Xylo Technologies to Expand in GERD Device Market

SciSparc (SPRC) stock saw a significant surge today, reaching $3.0497 as investors reacted positively to the company’s expansion into the high-growth GERD device market. This move is supported by SciSparc’s acquisition of Xylo Technologies, which will bring the MUSE endoscopic system to market. The system offers minimally invasive GERD treatment options. SciSparc aims to leverage this new technology and its existing expertise to expand its reach across key markets.